Objectivity matters. Today, more than ever. With no agenda, other than getting it right, Milliman’s Critical Point podcast takes a deep dive into subject matter that affects the health and well-being of people across the globe, from healthcare to retirement security, flood insurance to autonomous vehicles. Through a team of professionals ranging from actuaries to clinicians, technology specialists to economists, Critical Point examines the inherent challenges – and innovative solutions – that…
Subscribe:.rss.atom.json.md.m3u.pls
Live Last read · last published · next check
Saves to your Listen queue, to pick up on another day or another device.
Workers’ compensation insurance claims are staying open longer than ever, driving up costs and pushing more injured employees to litigate. On this episode of Critical Point, two workers’ comp experts—Milliman’s Stephanie Schmidt and the “Riskfluencer” Sandy Avina—unpack this trend and outline several cost-containment strategies for employers. They discuss the impact of comorbidities on workers’…
As the world changes, the role of property and casualty (P&C) actuaries is changing too, from the emerging risks they study—including climate change and self-driving cars—to the technologies they employ to devise solutions. On this episode of Critical Point, Milliman recruiter Liz Shickles speaks with two P&C actuarial consultants, Zora Law from Milliman and Dane Grand-Maison from partner firm…
Since 2005, the Milliman Medical Index (MMI) has estimated annual healthcare costs for people covered by a typical employer-sponsored health plan. To mark the 20th anniversary of the report, MMI authors past and present gathered to review how healthcare has changed over the past two decades. They discussed the impact of the Affordable Care Act and the COVID-19 pandemic, the rise in drug…
While the number of traditional pensions has been shrinking for decades, one type of defined benefit (DB) plan is expanding: the cash balance plan . Combining features of DB and 401(k) plans, cash balance plans are particularly well-suited to helping small-business owners and highly paid professionals such as doctors and lawyers save for retirement. On this episode of Critical Point, three…
In Europe, flooding was the most prevalent—and most expensive—climate peril last year, making 2024 the “Year of the Flood.” On this episode of Critical Point, five authors of Milliman’s annual Extreme Weather in Europe report assess the toll of flooding in their country and the response from insurers, governing bodies, and communities. They discuss what Italy is doing to protect the insurance…
AI has taken the world by storm—but not all insurance companies, or countries, are approaching the technology the same way. On this special episode of Critical Point, experts from Munich Re and Milliman who work across five continents come together for a global conversation exploring how insurers and regulators are approaching AI around the world. Plus, don’t miss Part 1 and Part 2 of this series…
Cell and gene therapies have been grabbing news headlines, both for their potential to cure rare diseases and for their million-dollar price tags. Milliman pharmacists and healthcare experts explain why state Medicaid agencies are particularly affected and the strategies many are using for predicting uptake and covering these high costs. You can read the episode transcript on our website .
Healthcare costs are a hot topic as we approach open enrollment and the presidential election. In this episode of Critical Point, host Deana Bell sits down with Dave Liner and Jason Clarkson, principals at Milliman and co-authors of the Milliman Medical Index (MMI), to discuss the key drivers of 2024’s healthcare costs. They dive into the effects of government programs like Medicaid and the…
Cyber risk, climate change, new pharmaceutical therapies—as companies look for ways to manage increasing costs and unforeseen exposures, captives are a popular mechanism to insure against the unexpected. Around since the 1950s, today there are more than 7,000 captive insurers worldwide, with many headquartered in Vermont, Bermuda, and the Cayman Islands. As these insurance vehicles grow in…
Drugmakers are taking steps to make sure clinical trials include participants from a variety of backgrounds—and they are steadily making progress, as evidenced by new studies of multiple sclerosis and sickle cell disease. Milliman health researchers Ellyn Russo and Chris Page unpack a history of distrust in medical research, the implications of failing to attract diverse study participants, and…